Expression of MMPs and TIMPs in liver fibrosis - a systematic review with special emphasis on anti-fibrotic strategies

被引:393
|
作者
Hemmann, Stefanie
Graf, Juergen
Roderfeld, Martin
Roeb, Elke
机构
[1] Univ Hosp Giessen & Marburg GmbH, Dept Med 2, D-35392 Giessen, Germany
[2] Univ Hosp Giessen & Marburg GmbH, Dept Anaesthesiol & Intens Care, D-35033 Marburg, Germany
关键词
liver; fibrosis; MMP; TIMP; matrix; metalloproteinase; tissue; inhibitor; therapy; expression;
D O I
10.1016/j.jhep.2007.02.003
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
In liver tissue matrix metalloproteinases (MMPs) and their specific inhibitors (tissue inhibitors of metalloproteinases, TIMPs) play a pivotal role in both, fibrogenesis and fibrolysis. The current knowledge of the pathophysiology of liver fibrogenesis with special emphasis on MMPs and TIMPs is presented. A systematic literature search was conducted. All experimental models of liver fibrosis that evaluated a defined anti-fibrotic intervention in vivo or in vitro considering MMPs and TIMPs were selected. The methodological quality of all these publications has been critically appraised using an objective scoring system and the content has been summarized in a table. (C) 2007 European Association for the Study of the Liver. Published by Elsevier BN. All rights reserved.
引用
收藏
页码:955 / 975
页数:21
相关论文
共 50 条
  • [1] Mechanisms of fibrolysis in chronic liver injury (with special emphasis on MMPs and TIMPs)
    Roderfeld, M.
    Hemmann, S.
    Roeb, E.
    ZEITSCHRIFT FUR GASTROENTEROLOGIE, 2007, 45 (01): : 25 - 33
  • [2] FIBROSIS IN EB - MECHANISMS AND ANTI-FIBROTIC STRATEGIES
    Nystroem, Alexander
    ACTA DERMATO-VENEREOLOGICA, 2020, 100 : 7 - 7
  • [3] Prognosis of idiopathic pulmonary fibrosis without anti-fibrotic therapy: a systematic review
    Khor, Yet H.
    Ng, Yvonne
    Barnes, Hayley
    Goh, Nicole S. L.
    McDonald, Christine F.
    Holland, Anne E.
    EUROPEAN RESPIRATORY REVIEW, 2020, 29 (157): : 1 - 16
  • [4] A HUMAN MODEL OF LUNG FIBROSIS FOR THE ASSESSMENT OF ANTI-FIBROTIC STRATEGIES IN IDIOPATHIC PULMONARY FIBROSIS
    Roach, K. M.
    Tongue, P.
    Castells, E.
    Elliot, G.
    Marshall, H.
    Richardson, M.
    Mason, S.
    Chachi, L.
    Bradding, P.
    THORAX, 2019, 74 : A56 - A57
  • [5] Anti-fibrotic effect of Cordyceps sinensis polysaccharide: Inhibiting HSC activation, TGF-β1/Smad signalling, MMPs and TIMPs
    Peng, Jinghua
    Li, Xuemei
    Feng, Qin
    Chen, Liang
    Xu, Lili
    Hu, Yiyang
    EXPERIMENTAL BIOLOGY AND MEDICINE, 2013, 238 (06) : 668 - 677
  • [6] Expression of pro-fibrotic and anti-fibrotic molecules in dimethylnitrosamine-induced hepatic fibrosis
    Sferra, Roberta
    Vetuschi, Antonella
    Pompili, Simona
    Gaudio, Eugenio
    Speca, Silvia
    Latella, Giovanni
    PATHOLOGY RESEARCH AND PRACTICE, 2017, 213 (01) : 58 - 65
  • [7] Anti-fibrotic activity of natural products, herbal extracts and nutritional components for prevention of liver fibrosis: review
    El-Tantawy, Walid Hamdy
    Temraz, Abeer
    ARCHIVES OF PHYSIOLOGY AND BIOCHEMISTRY, 2022, 128 (02) : 382 - 393
  • [8] Boiling histotripsy exhibits anti-fibrotic effects in animal models of liver fibrosis
    Joung, Chanmin
    Heo, Jeongmin
    Pahk, Ki Joo
    Pahk, Kisoo
    SCIENTIFIC REPORTS, 2024, 14 (01):
  • [9] Enhancing Anti-Fibrotic Properties of Mesenchymal Stem Cells for the Treatment of Liver Fibrosis
    Verma, A.
    Kamberi, S.
    Fontaine, M.
    Civin, C.
    Maluf, D.
    Mas, V.
    Meier, R.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2023, 23 (06) : S927 - S927
  • [10] Anti-Fibrotic Effects of Ganoderma Lucidum and Praziquantel on Liver Fibrosis of Schistosoma japonicum
    Xu, Huijuan
    Zhu, Yangquan
    Shuai, Lianyun
    JOURNAL OF ANIMAL AND VETERINARY ADVANCES, 2012, 11 (13): : 2342 - 2346